Sharing of heart failure model

ELK Biotechnology

01 Background

Heart failure (HF) refers to a series of complex clinical syndromes such as cardiac circulatory disorders caused by impaired contractile and/or diastolic functions of the heart, which cannot fully discharge venous return blood from the heart, leading to blood congestion in the venous system and insufficient blood perfusion in the arterial system. Its incidence and mortality rates are increasing year by year, seriously endangering human health.

Myocardial damage caused by any reason, such as myocardial infarction, cardiomyopathy, hemodynamic overload, inflammation, etc., can cause changes in myocardial structure and function, leading to poor ventricular pumping and/or filling function, and ultimately inducing heart failure.

The main clinical manifestations of heart failure are dyspnea, fatigue, pulmonary congestion and peripheral edema. The research on the pathogenesis and intervention treatment of heart failure is far from meeting clinical requirements, which requires the establishment of a mature and stable animal model of heart failure to understand the disease process and study new treatment methods.

?02 Experimental materials and methods

?Experimental materials:?

◆ SD rats (male, 180-220g)

◆ Isoflurane

◆ Animal ventilator

◆ Universal small animal anesthesia machine

Modeling method:?1. Adaptive feeding for 7 days, using isoflurane and fat emulsion to make emulsified isoflurane, and intraperitoneally injecting anesthesia to the rats. 2. Cut the neck, bluntly separate the trachea, intubate through the mouth, connect the ventilator, and use the pre-adjusted parameters (rat respiratory rate 80, respiratory ratio 1:1, tidal volume 6.4) to bluntly separate the left chest muscles, expose the intercostal space, tear the muscles from the third and fourth intercostal spaces, expose the heart, gently tear open a little pericardium, and insert the needle between the left atrial appendage and the arterial cone with a 6-0 suture needle. The ST elevation on the electrocardiogram indicates successful ligation. Then suture the intercostal muscles and chest muscles, remove the ventilator after 5-10 minutes, and wait for the mouse to recover spontaneous breathing and place it in a cage. 3. Take the heart tissue 4-8 weeks after the modeling is completed.

Evaluation indicators:?serum index ELISA test, Masson staining, HE staining.

03 Model verification

◆?Masson staining

◆?HE staining

Related product recommendations??

ELK1158 Rat IL6(Interleukin 6) ELISA Kit

Rat ELK1157 Mouse IL6(Interleukin 6) ELISA Kit

ELK1156 Human IL6(Interleukin 6) ELISA Kit

ELK1056 Mouse CRP(C Reactive Protein) ELISA Kit

ELK1055 Rat CRP(C Reactive Protein) ELISA Kit

ELK1040 Human CRP(C Reactive Protein) ELISA Kit

ELK1286 Mouse CKMB(Creatine Kinase MB Isoenzyme) ELISA Kit

ELK2693 Rat CKMB(Creatine Kinase MB Isoenzyme) ELISA Kit

ELK5085 Human CKMB(Creatine Kinase MB Isoenzyme) ELISA Kit

ELK3961 Human cTnT/TNNT2(Troponin T Type 2, Cardiac) ELISA Kit

ELK6207 Mouse cTnT/TNNT2(Troponin T Type 2, Cardiac) ELISA Kit

ELK6263 Rat cTnT/TNNT2(Troponin T Type 2, Cardiac) ELISA Kit Rat

ELK9080 Human hs-cTnI (High Sensitivity Cardiac Troponin I) ELISA Kit

ELK9212 Rat hs-cTnI(High Sensitivity Cardiac Troponin I) ELISA Kit

ELK5227 Mouse BNP(Brain Natriuretic Peptide) ELISA Kit

ELK5430 Human BNP(Brain Natriuretic Peptide) ELISA Kit

ELK5457 Rat BNP(Brain Natriuretic Peptide) ELISA Kit Rat ELK1212 Human NT-ProBNP(N-Terminal Pro-Brain Natriuretic Peptide) ELISA Kit ELK5445 Mouse NT-ProBNP(N-Terminal Pro-Brain Natriuretic Peptide) ELISA Kit ELK8211 Rat NT-ProBNP(N-Terminal Pro-Brain Natriuretic Peptide) ELISA Kit